216 related articles for article (PubMed ID: 18829174)
1. Is exercise beneficial to the inflammatory bowel diseases? An implication of heat shock proteins.
Chen Y; Noble EG
Med Hypotheses; 2009 Jan; 72(1):84-6. PubMed ID: 18829174
[TBL] [Abstract][Full Text] [Related]
2. Immunological aspects of heat-shock proteins-the optimum stress of life.
Prohászka Z; Füst G
Mol Immunol; 2004 May; 41(1):29-44. PubMed ID: 15140573
[TBL] [Abstract][Full Text] [Related]
3. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases.
Van Eden W; Wick G; Albani S; Cohen I
Ann N Y Acad Sci; 2007 Oct; 1113():217-37. PubMed ID: 17584980
[TBL] [Abstract][Full Text] [Related]
4. Role of heat shock proteins (molecular chaperones) in intestinal mucosal protection.
Otaka M; Odashima M; Watanabe S
Biochem Biophys Res Commun; 2006 Sep; 348(1):1-5. PubMed ID: 16875664
[TBL] [Abstract][Full Text] [Related]
5. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel diseases and brain-gut axis.
Hollander D
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():183-90. PubMed ID: 15075459
[TBL] [Abstract][Full Text] [Related]
7. Manipulating heat shock protein expression in laboratory animals.
Tolson JK; Roberts SM
Methods; 2005 Feb; 35(2):149-57. PubMed ID: 15649841
[TBL] [Abstract][Full Text] [Related]
8. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
Hatoum OA; Heidemann J; Binion DG
Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192
[TBL] [Abstract][Full Text] [Related]
9. Rationale for probiotic treatment strategies in inflammatory bowel disease.
Schultz M; Lindström AL
Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
[TBL] [Abstract][Full Text] [Related]
10. Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients.
Wojtal KA; Eloranta JJ; Hruz P; Gutmann H; Drewe J; Staumann A; Beglinger C; Fried M; Kullak-Ublick GA; Vavricka SR
Drug Metab Dispos; 2009 Sep; 37(9):1871-7. PubMed ID: 19487253
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
Yang GY; Taboada S; Liao J
Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of inflammatory bowel disease.
Byrne FR; Viney JL
Curr Opin Drug Discov Devel; 2006 Mar; 9(2):207-17. PubMed ID: 16566291
[TBL] [Abstract][Full Text] [Related]
13. Inducible heat shock protein 70 and its role in preconditioning and exercise.
Madden LA; Sandström ME; Lovell RJ; McNaughton L
Amino Acids; 2008 May; 34(4):511-6. PubMed ID: 18046502
[TBL] [Abstract][Full Text] [Related]
14. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours.
Wedemeyer J; Vosskuhl K
Best Pract Res Clin Gastroenterol; 2008; 22(3):537-49. PubMed ID: 18492570
[TBL] [Abstract][Full Text] [Related]
15. [Inflammatory bowel disease: IBD].
Endo K; Shiga H; Kinouchi Y; Shimosegawa T
Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
[TBL] [Abstract][Full Text] [Related]
16. Understanding why probiotic therapies can be effective in treating IBD.
Fedorak RN
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
[TBL] [Abstract][Full Text] [Related]
17. Heat-shock proteins and atherosclerosis.
Ferreira MB; Carlos AG
Allerg Immunol (Paris); 2002 Jun; 34(6):204-7. PubMed ID: 12134643
[TBL] [Abstract][Full Text] [Related]
18. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
20. DNA-driven nutritional therapy of inflammatory bowel disease.
Lee G; Buchman AL
Nutrition; 2009 Sep; 25(9):885-91. PubMed ID: 19647622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
